Concepedia

Publication | Open Access

Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial

DOIFull Paper Access

120

Citations

31

References

2021

Year

Yoland Antill, Peey‐Sei Kok, Kristy Robledo, Sonia Yip, Michelle M. Cummins, Deborah S. Smith, Amanda B. Spurdle, Elizabeth H Barnes, Yeh Chen Lee, Michael Friedländer,
Journal for ImmunoTherapy of Cancer

Abstract

ANZGOG1601, ACTRN12617000106336, and NCT03015129.

References

YearCitations

Page 1